Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of kinase inhibitors for cancer treatment. Its structure allows for strong binding interactions with biological targets due to the electron-withdrawing trifluoromethyl group. Also employed in agrochemical research for designing novel pesticides with improved stability and activity. The compound’s polarity and hydrogen bonding capability make it suitable for enhancing solubility and bioavailability in drug candidates.